Zhejiang Hisun Pharmaceutical Co Ltd (600267) — Net Asset Quality Index

Latest as of March 2026: 66.6%

Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Net Asset Quality Index of 66.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥13.81 Billion minus total liabilities of CN¥4.62 Billion yields net assets of CN¥9.20 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Zhejiang Hisun Pharmaceutical Co Ltd's assets to evaluate the company's liquid asset resilience ratio.

Quality Index

66.6%
Equity / Total Assets

Net Assets

CN¥9.20 Billion
CNY

Total Assets

CN¥13.81 Billion
CNY

Total Liabilities

CN¥4.62 Billion
CNY

Zhejiang Hisun Pharmaceutical Co Ltd Net Asset Quality Index Over Time (1997–2025)

This chart shows how Zhejiang Hisun Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 29 annual periods from 1997 to 2025. As of March 2026, the index stands at 66.6%, representing net assets of CN¥9.20 Billion against total assets of CN¥13.81 Billion CNY. See 600267 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Zhejiang Hisun Pharmaceutical Co Ltd (1997–2025)

The table below presents the year-by-year Net Asset Quality Index for Zhejiang Hisun Pharmaceutical Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Zhejiang Hisun Pharmaceutical Co Ltd stock valuation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 58.8% CN¥8.85 Billion CN¥15.05 Billion CN¥6.20 Billion ▲ +5.1 pp
2024 53.7% CN¥8.58 Billion CN¥15.97 Billion CN¥7.39 Billion ▲ +6.3 pp
2023 47.4% CN¥8.35 Billion CN¥17.61 Billion CN¥9.26 Billion ▲ +3.0 pp
2022 44.4% CN¥8.33 Billion CN¥18.78 Billion CN¥10.45 Billion ▲ +6.4 pp
2021 37.9% CN¥7.35 Billion CN¥19.37 Billion CN¥12.03 Billion ▼ -1.7 pp
2020 39.6% CN¥8.26 Billion CN¥20.86 Billion CN¥12.60 Billion ▲ +3.8 pp
2019 35.8% CN¥7.68 Billion CN¥21.47 Billion CN¥13.78 Billion ▲ +2.0 pp
2018 33.8% CN¥7.38 Billion CN¥21.85 Billion CN¥14.48 Billion ▼ -2.6 pp
2017 36.4% CN¥7.88 Billion CN¥21.64 Billion CN¥13.76 Billion ▼ -2.3 pp
2016 38.7% CN¥8.04 Billion CN¥20.76 Billion CN¥12.72 Billion ▼ -3.9 pp
2015 42.6% CN¥8.17 Billion CN¥19.17 Billion CN¥11.01 Billion ▼ -5.2 pp
2014 47.8% CN¥8.26 Billion CN¥17.30 Billion CN¥9.03 Billion ▲ +5.1 pp
2013 42.6% CN¥5.96 Billion CN¥13.97 Billion CN¥8.01 Billion ▼ -6.5 pp
2012 49.2% CN¥5.20 Billion CN¥10.57 Billion CN¥5.37 Billion ▼ -6.6 pp
2011 55.8% CN¥4.59 Billion CN¥8.23 Billion CN¥3.64 Billion ▲ +9.5 pp
2010 46.3% CN¥2.74 Billion CN¥5.92 Billion CN¥3.18 Billion ▼ -0.4 pp
2009 46.8% CN¥2.43 Billion CN¥5.20 Billion CN¥2.77 Billion ▲ +9.2 pp
2008 37.6% CN¥1.55 Billion CN¥4.12 Billion CN¥2.57 Billion ▼ -8.5 pp
2007 46.1% CN¥1.38 Billion CN¥2.99 Billion CN¥1.61 Billion ▲ +1.0 pp
2006 45.2% CN¥1.27 Billion CN¥2.81 Billion CN¥1.54 Billion ▼ -2.0 pp
2005 47.1% CN¥1.23 Billion CN¥2.61 Billion CN¥1.38 Billion ▼ -8.0 pp
2004 55.1% CN¥1.20 Billion CN¥2.18 Billion CN¥977.76 Million ▲ +1.7 pp
2003 53.5% CN¥1.00 Billion CN¥1.87 Billion CN¥871.96 Million ▲ +1.1 pp
2002 52.4% CN¥824.83 Million CN¥1.58 Billion CN¥750.69 Million ▼ -8.0 pp
2001 60.4% CN¥784.18 Million CN¥1.30 Billion CN¥514.75 Million ▼ -2.4 pp
2000 62.8% CN¥757.90 Million CN¥1.21 Billion CN¥449.01 Million ▲ +25.6 pp
1999 37.2% CN¥249.88 Million CN¥672.12 Million CN¥422.24 Million ▼ -3.4 pp
1998 40.6% CN¥196.50 Million CN¥483.70 Million CN¥287.20 Million ▼ -11.6 pp
1997 52.2% CN¥184.23 Million CN¥352.91 Million CN¥168.68 Million
pp = percentage points